Homeway Technology Co., Ltd.
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Homeway ranks #47,472 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.
- #47,472
- of 49,997 US assignees by volume
- 20th percentile
- by Innovation Score (26.4/100)
- 7.0
- avg claims per patent
- +50%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R47472 · Foreign Corporation #47,472 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #47,472/49,997
- PHOTO-FINISH Holder SAS
- CPC-NARROW A61F · 7 areas
- INNOV-THIN 26.4/100
- CLAIMS-SPARSE 7.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +50% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Holder SAS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Homeway’s 26.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Homeway
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Homeway Technology · this assignee 26
Homeway Technology · this assignee
26 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Homeway's Innovation Score is 26.4/100 (20th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Homeway?
Each dot is one of Homeway’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Homeway’s own 7.0 claims/patent is at or below the 11.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Homeway's grants concentrate
Homeway Technology Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 40% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). By volume, Homeway sits between Holder SAS and Hongkong Fingu Development Company Limited.
Homeway's three-year grant acceleration
Homeway Technology Co., Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Homeway's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Holder SAS
Holder SAS
5 patents
- Holmatro B V
Holmatro B.V.
5 patents
- Holygo
Holygo Corporation
5 patents
- Homeease Industri…
Homeease Industrial Co., Ltd.
5 patents
- Honbusankei
Honbusankei Co., Ltd.
5 patents
- Honeywell Romania…
Honeywell Romania S.R.L.
5 patents
- Hongfujin Precisi…
Hongfujin Precision Electrons (YANTAI) Co., Ltd.
5 patents
- Hongkong Fingu De…
Hongkong Fingu Development Company Limited
5 patents
- Homeway Technology ◀
Homeway Technology Co., Ltd.
5 patents
What this shows Homeway holds 5 patents at rank #47,388, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Homeway
By rank, the assignees closest to #47,388 in granted patent volume.
- Holder SAS #47,384 · 5 patents
- Holmatro B.V. #47,385 · 5 patents
- Holygo Corporation #47,386 · 5 patents
- Homeease Industrial Co., Ltd. #47,387 · 5 patents
- Honbusankei Co., Ltd. #47,389 · 5 patents
- Honeywell Romania S.R.L. #47,390 · 5 patents
- Hongfujin Precision Electrons (YANTAI) Co., Ltd. #47,391 · 5 patents
- Hongkong Fingu Development Company Limited #47,392 · 5 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Homeway's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Homeway's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 20th percentile higher than 20% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Which technologies does Homeway Technology Co., Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Homeway Technology Co., Ltd.'s patent record in context - here's where to go next.
- Homeway Technology Co., Ltd.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 40% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #47,472 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Homeway Technology Co., Ltd. against Holder SAS, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.